Pharma M&A deal value up 31% YoY in 2025YTD amid return of mega-deals [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
to $179.6 billion in 2025 year-to-date (YTD), following a previous year characterised by smaller, bolt-on transactions, according to GlobalData's Pharma Intelligence Center Deals Database. In the first half (H1) of 2025, uncertainty surrounding US President Trump's policies heightened the perceived risk of large-scale M&A. This led to drug manufacturers limiting their M&A activity to transactions valued under $5 billion, with exceptions including Johnson & Johnson's $14.6 billion acquisition of Intracellular Therapies and Sanofi's $9.5 billion acquisition of Blueprint Medicines. As large pharmaceutical companies adapted to Trump's tariffs and drug pricing policies, deal-making uncertainty began to ease. In addition, Federal Trade Commission (FTC) deregulation under the Trump administration, combined with recent interest rate cuts by the Federal Reserve, alleviated challenges hindering pharmaceutical companies from signing larger deals. As a result, the third quarter (Q3) of 2025 w
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- DGRO: Dividend Growth And Leading Companies Make This Fund A Buy [Seeking Alpha]Seeking Alpha
- 2 Recession-Proof Stocks to Watch in December [Yahoo! Finance]Yahoo! Finance
- Valerie Health raises $30 million Series A to scale “AI front offices” for physicians [Fortune]Fortune
- Johnson & Johnson: Quality Compounding, Valuations Now Do The Heavy Lifting [Seeking Alpha]Seeking Alpha
- Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter ResultsBusiness Wire
JNJ
Earnings
- 10/14/25 - Beat
JNJ
Sec Filings
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- JNJ's page on the SEC website